GB1189973A - Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides - Google Patents
Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-NucleosidesInfo
- Publication number
- GB1189973A GB1189973A GB810769A GB810769A GB1189973A GB 1189973 A GB1189973 A GB 1189973A GB 810769 A GB810769 A GB 810769A GB 810769 A GB810769 A GB 810769A GB 1189973 A GB1189973 A GB 1189973A
- Authority
- GB
- United Kingdom
- Prior art keywords
- didesoxy
- nucleosides
- oxygen
- cytostatically
- fluoropyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Abstract
1,189,973. Pyrimidine nucleosides. DEUTSCHE AKADEMIE DER WISSENSCHAFTEN ZU BERLIN. 14 Feb., 1969, No. 8107/69. Heading C2C. Novel, cytoatatically active compounds I wherein X is oxygen, sulphur or imino and R is hydrogen, halogen, hydroxy, mercapto or unsubstituted or substituted alkyl, are obtained by reacting a corresponding pyrimidine nucleoside, appropriately substituted on the oxygen of the 3<SP>1</SP>-hydroxy group, with a fluoronation agent. 2<SP>1</SP>,3<SP>1</SP>-Didehydro-3<SP>1</SP>-desoxy-thymidine is prepared by treating 1-(2<SP>1</SP>,3<SP>1</SP>-didesoxy-3<SP>1</SP>-fluoro- #-D-pentofuranosyl)-thymine (a compound of the invention) with aqueous alcoholic sodium hydroxide solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB810769A GB1189973A (en) | 1969-02-14 | 1969-02-14 | Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB810769A GB1189973A (en) | 1969-02-14 | 1969-02-14 | Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1189973A true GB1189973A (en) | 1970-04-29 |
Family
ID=9845901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB810769A Expired GB1189973A (en) | 1969-02-14 | 1969-02-14 | Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1189973A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0254268A2 (en) * | 1986-07-24 | 1988-01-27 | The Wellcome Foundation Limited | Fluorinated nucleosides,their preparation and their pharmaceutical use against AIDS |
EP0305117A2 (en) * | 1987-08-22 | 1989-03-01 | The Wellcome Foundation Limited | 2',3'-Dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections |
-
1969
- 1969-02-14 GB GB810769A patent/GB1189973A/en not_active Expired
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0254268A2 (en) * | 1986-07-24 | 1988-01-27 | The Wellcome Foundation Limited | Fluorinated nucleosides,their preparation and their pharmaceutical use against AIDS |
EP0254268A3 (en) * | 1986-07-24 | 1988-07-13 | Akademie Der Wissenschaften Der Ddr | Fluorinated nucleoside, process for their preparation and their use as a pharmaceutical product against aids |
AU615431B2 (en) * | 1986-07-24 | 1991-10-03 | Wellcome Foundation Limited, The | Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids) |
EP0305117A2 (en) * | 1987-08-22 | 1989-03-01 | The Wellcome Foundation Limited | 2',3'-Dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections |
EP0305117A3 (en) * | 1987-08-22 | 1989-12-27 | The Wellcome Foundation Limited | 2',3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections |
US5070078A (en) * | 1987-08-22 | 1991-12-03 | Burroughs Wellcome Co. | Antiviral compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8300785A1 (en) | Androstene 17 alpha -carbonate 17 beta -carboxylates (and carbothioates) | |
MX247325B (en) | PROCEDURE FOR OBTAINING TRIAZOLINTIONA DERIVATIVES. | |
SE336864B (en) | ||
ES8604640A1 (en) | Bleaching compositions. | |
GB1374471A (en) | Azetidinone derivatives | |
IT1196261B (en) | 8-SUBSTITUTED NUCLEOSIDIC AND PURINIC DERIVATIVES | |
GB1063007A (en) | A process for etching printed circuits | |
GB1189973A (en) | Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides | |
GR3003576T3 (en) | ||
ES8500896A1 (en) | Benzoyl ureas. | |
ES369952A1 (en) | Certain diisoniazid methane sulfonate complexes | |
ES285616A1 (en) | A procedure for the manufacture of uridine derivatives (Machine-translation by Google Translate, not legally binding) | |
GB1227692A (en) | ||
GB1236553A (en) | New heterocyclic n,n-diglycidyl compounds, processes for their manufacture and their use | |
ES8602352A1 (en) | Derivatives of 2-alkoxyaminosulfonylbenzenesulfonylurea. | |
GB1304812A (en) | ||
GB1249538A (en) | Adenosine derivatives | |
GB1180216A (en) | Dithiocarbamates | |
GB1050489A (en) | ||
GB1348065A (en) | Production of sulphonyl ureas | |
FR2075551A5 (en) | ||
NL6907520A (en) | ||
GB1483684A (en) | Benzothiazole derivatives | |
KR840001957A (en) | Method for preparing novel isopropyl amino pyrimidine derivatives | |
GB1289918A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |